Introduction
Coronary artery disease (CAD) and myocardial infarction (MI) are the leading causes of morbidity and mortality in the Western world [1] . In epidemiological studies, factors like smoking, obesity, high blood pressure, elevated cholesterol levels, and diabetes have been identified to increase cardiovascular risk. Additionally, a strong genetic component was also documented in the etiology of CAD [2, 3] . To unravel the underlying genes, several genomewide analyses have been performed and revealed chromosomal loci with linkage to CAD or MI [4] [5] [6] [7] [8] [9] [10] [11] [12] . However, until today only few genes and variants responsible for prevalence to MI in the general population are known [9, 13] .
In the pathophysiology of atherosclerosis, inflammation is hypothesized to play an important role for plaque formation and its destabilization and therefore causing CAD and MI [14, 15] .
Complement factor H (CFH) as a part of innate immunity contributes to inflammation processes. CFH provides binding sites for C3b, heparin as well as sialic acids, and also interacts with C-reactive protein (CRP) [16] , which has been linked in several studies to CAD, MI and stroke [17] .
Recently, an association between a common CFH gene variant and increased risk for MI was reported in a prospective cohort study: Single nucleotide polymorphism (SNP) rs1061170, representing a tyrosine-histidine change at amino acid position 402 in the CFH protein, showed hazard ratios up to 1.77 in 226 MI cases during a mean of 8.4 years of follow-up of 5,237 individuals from the Rotterdam Study [18] . However, another prospective study with 335 MI cases did not show an influence of Y402H variant on susceptibility to MI [19] .
The German MI family study [4, [20] [21] [22] ] provides well-characterized MI patients as well as unrelated, healthy controls for association studies. Here, we investigated the association between the CFH-Y402H genetic variant and susceptibility to MI and known cardiovascular risk factors, as well as CRP serum levels. 
Methods

Study sample
The study sample consisted of individuals from the German MI family study. Selection criteria have been described previously [4, 20] . All participants were studied by standardized questionnaire, physical examination and biochemical analyses at inclusion (n=2,161) and five-year follow-up (n=1,780).
Baseline characteristics of the 2,161 investigated participants in this study at the time point of inclusion are summarized in Table 1 . The present analyses included independent MI cases (n=1,188) with a positive family history (at least one additional family member who had suffered from MI or severe CAD, defined as treatment with percutaneous coronary intervention or coronary artery bypass graft). Control individuals (n=973) consisted of married-in spouses, sisters-in-law, and brothers-in-law, respectively. Thereof, 617 controls were confirmed to be free of any cardiovascular symptoms and events during the follow-up 
Definition of risk factors
Diabetes was defined as a history of diabetes mellitus or intake of antidiabetic medication.
Individuals with former or current smoking habit were classified as smokers. Obesity was defined as body mass index ≥ 30 kg/m². Study subjects receiving antihypertensive therapy or with a systolic blood pressure (BP) ≥ 140 mmHg or diastolic BP ≥ 90 mmHg were classified as hypertensive. Hypercholesterolemia was defined as low-density lipoprotein (LDL) cholesterol ≥ 160 mg/dL or use of a lipid lowering therapy.
Genetic analysis
Genomic DNA was isolated from whole blood samples using the PureGene DNA Purification System Blood Kit (Gentra, Minneapolis, MN, USA). DNA samples were genotyped using 5' 
Statistical analysis
Genotype distribution within the groups of cases and controls, respectively, was compared with values predicted by Hardy-Weinberg equilibrium using the χ²-test. Differences in allele frequencies between dichotomous traits were calculated with the same method. Genotype distribution between cases and controls assuming dominant or recessive genetic models were performed using logistic regression analysis. Linear regression analysis was employed for comparison of genotype distributions with continuous variables, whereas ln(CRP) serum levels were used. Potential interaction between each traditional cardiovascular risk factor and genotype was tested in separate logistic regression analyses including cross-product term.
Prevalence odds ratios (OR) with their 95% confidence intervals (CI) were reported. A twosided P value ≤ 0.05 was considered statistically significant. All analyses were carried out 
Results
From 2,187 DNA specimens, a total of 2,161 individuals were genotyped successfully and therefore the overall call rate was 98.8 %. Baseline characteristics of this study sample are shown in Table 1 . The proportion of women was lower in the patient group (n=375) than in the control group (n=636). As expected, the MI patients (n=1,188) had a higher prevalence of classical cardiovascular risk factors (hypercholesterolemia, hypertension, obesity, diabetes, and smoking habit) than did the control subjects (n=973). In MI patients, the mean age at first MI was 51.4 ± 8.4 years. Anthropometric and biochemical measurement were performed at time-point of inclusion at a mean age of 57.9 ± 9.2 years (58.7 ± 8.6 years for MI patients, 56.9 ± 9.8 years for controls).
Genotype distribution of CFH gene variant Y402H was analyzed in the whole population and in sub-groups separately. The Hardy-Weinberg equilibrium was always fulfilled. Hence, test for allele frequency difference and co-dominant model gave nearly the same P values (not shown). Therefore, additional to the allele frequency comparisons we reported results from dominant and recessive genetic models (Table 2 ). In our study with 2,161 different DNA samples, the frequency of the H allele was 36.7%. Genotype frequencies in the whole study group were 40.4%, 45.8%, and 13.8% for YY, YH, and HH, respectively.
CFH-Y402H variant and susceptibility to MI and risk factors
The observed allele frequency and genotype distributions of the CFH-Y402H variant were not significantly different between 1,188 MI cases and 973 unaffected controls. In addition, no association could be found between the Y402H variant and classical cardiovascular risk factors, namely diabetes, hypercholesterolemia, hypertension, obesity, and smoking habit ( CFH-Y402H genotypes and CRP serum levels from the follow-up examination could be found (data not shown).
Additional analysis in a age-and sex-matched sub-sample (n=1,200) with 300 cases and 300 controls from both men and women also showed no association between risk factors, MI and
CFH-Y402H genotypes (data not shown).
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Discussion
Inflammation and components of the innate immunity -and thereby potentially complement activation -play a major role in the pathophysiology of atherosclerosis [26] . The CFH gene, encoding a plasma protein essential for regulation of the alternative complement pathway, is a good candidate for genetic susceptibility to MI. Two recent studies showed inconsistent results on the association of CFH-Y402H variant with MI in prospective cohorts [18, 19] .
Thus, additional data is needed to assess the impact of this variant to the genetic etiology of MI.
In the present case-control association study, the CFH-Y402H variant was neither associated with an increased risk for MI in patients with a strong familial background for cardiovascular disease nor with classical cardiovascular risk factors, such as diabetes mellitus, hypercholesterolemia, hypertension, obesity, and smoking ( serum level at follow-up examination is not associated with susceptibility to MI in our study.
However, it has to be noted that in this study group baseline as well as follow-up values for serum CRP are measured after a mean of 7.3 and 11.8 years, respectively, after suffering from MI. It is thus questionable whether these values can be related to the pathophysiology of the MI event.
Within the CFH gene the amino acid position 402 is encoded in exon 9. This region is part of a strong linkage disequilibrium (LD) block that did not cover the whole gene with respect to a r² value of 0.8 by analyzing data from the HapMap project [30] . However, Y402H variant is the only one so far showing positive association with MI in a prospective cohort study [18] . In upcoming genome-wide association (GWA) studies on MI, e. g. using Affymetrix © GeneChip ® Human Mapping 500K Array Set, CFH-Y402H variant will not be analyzed directly due to absence of this SNP on the chips. Altogether, information of 18 SNPs within the 95.5-kb CFH gene will be available from these GWA studies. Recent studies on the CFH gene dealing with association between the Y402H variant and age-related macular degeneration showed that other polymorphisms within the CFH gene also contribute to disease susceptibility independent from Y402H genotype [31, 32] . This emphasises the relevance of analyzing the Tables   Table 1. Characteristics of study sample from the German MI family study Unadjusted odds ratios (OR) are given * Definition is given in Table 1 
